These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7397063)

  • 1. Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.
    Perez J; Sitar DS; Ogilvie RI
    Br J Clin Pharmacol; 1980 May; 9(5):471-8. PubMed ID: 7397063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.
    Alván G; Helleday L; Lindholm A; Sanz E; Villén T
    Br J Clin Pharmacol; 1990 Feb; 29(2):215-9. PubMed ID: 2306413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.
    Alván G; Paintaud G; Eckernäs SA; Grahnén A
    Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of age on renal and extrarenal effects of frusemide.
    Andreasen F; Hansen U; Husted SE; Mogensen CE; Pedersen EB
    Br J Clin Pharmacol; 1984 Jul; 18(1):65-74. PubMed ID: 6743491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of furosemide in patients with acute pulmonary edema.
    Perez J; Sitar DS; Ogilvie RI
    Drug Metab Dispos; 1979; 7(6):383-7. PubMed ID: 43224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of frusemide on pulmonary blood volume.
    Bhatia ML; Singh I; Manchanda SC; Khanna PK; Roy SB
    Br Med J; 1969 May; 2(5656):551-2. PubMed ID: 5769890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man.
    Marone C; Muggli F; Lahn W; Frey FJ
    Eur J Clin Invest; 1985 Oct; 15(5):253-7. PubMed ID: 3935455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frusemide and pulmonary oedema.
    Tattersfield AE; McNicol MW
    Lancet; 1971 May; 1(7705):911. PubMed ID: 4102050
    [No Abstract]   [Full Text] [Related]  

  • 11. Attenuation by phenylbutazone of the renal effects and excretion of frusemide in horses.
    Dyke TM; Hinchcliff KW; Sams RA
    Equine Vet J; 1999 Jul; 31(4):289-95. PubMed ID: 10454086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of pharmacokinetics and effects on urinary secretion of electrolytes of furosemide and furosemide-amiloride in healthy subjects].
    Kantelip JP; Aiache JM; Beyssac E; Abella ML
    Therapie; 1991; 46(6):475-9. PubMed ID: 1819153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
    Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T
    J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
    Hammarlund MM; Odlind B; Paalzow LK
    J Pharmacol Exp Ther; 1985 May; 233(2):447-53. PubMed ID: 3999028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between five oral frusemide preparations using renal chloride excretion and frusemide recovery.
    Eggers NJ; Kingsford M; Saint Joly CM; Jellett LB; Shirkey RJ
    N Z Med J; 1983 Nov; 96(744):963-6. PubMed ID: 6355931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
    Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
    Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.